Severe myalgia associated with brodalumab treatment in a patient with psoriasis

J Dermatol. 2018 Dec;45(12):e327-e328. doi: 10.1111/1346-8138.14474. Epub 2018 May 21.

Authors

Susumu Ichiyama¹, Yoko Matano¹, Toshihiko Hoashi¹, Naoko Kanda², Hiroshi Nagayama³, Hidehisa Saeki¹

Affiliations

¹ Department of Dermatology, Nippon Medical School, Tokyo, Japan.
² Department of Dermatology, Nippon Medical School Chiba Hokusoh Hospital, Chiba, Japan.
³ Department of Neurological Science, Graduate School of Medicine, Nippon Medical School, Tokyo, Japan.

PMID: 29782052
DOI: 10.1111/1346-8138.14474

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Antibodies, Monoclonal / adverse effects*
Antibodies, Monoclonal, Humanized
Dermatologic Agents / adverse effects*
Female
Humans
Middle Aged
Myalgia / chemically induced*
Myalgia / diagnosis
Psoriasis / drug therapy*
Severity of Illness Index

Substances

Antibodies, Monoclonal
Antibodies, Monoclonal, Humanized
Dermatologic Agents
brodalumab